Trial intelligence / Profile preview

FOX-E: Eniluracil + 5-FU + Oxaliplatin in Previously-Treated Colorectal Cancer

NCT00005050Phase 2Completed

Sponsor
NYU Langone Health
Start
Aug 1999
Primary completion
Jun 2001
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of eniluracil in colorectal cancer (CRC), sponsored by NYU Langone Health. Started Aug 1999; status: completed.

02

Drugs

eniluracil
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT00005050.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00005050.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call